--- title: "Avantor (AVTR) stock listing, news and investor profile" url: "https://aibio.space/companies/avantor/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Avantor, Inc. (NYSE: AVTR), United States. Listing facts, related biotech companies and news on aibio.space." --- AVTR Avantor, Inc. NYSE · United States # Avantor (AVTR) news Avantor, Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker AVTR, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Avantor news We have not published a story on Avantor yet. When there is news, it will appear here. ## Avantor at a glance - **Ticker**: AVTR - **Listing**: NYSE - **Country**: United States - **Cash, Sep 30, 2026**: $464.3 million ### Related companies - [Precipio](https://aibio.space/companies/precipio/) NASDAQ: PRPO - [PACIFIC BIOSCIENCES OF CALIFORNIA, INC.](https://aibio.space/companies/pacific-biosciences-of-california/) NASDAQ: PACB - [VivoSim Labs, INC.](https://aibio.space/companies/vivosim-labs/) NASDAQ: VIVS - [STAAR SURGICAL CO](https://aibio.space/companies/staar-surgical/) NASDAQ: STAA - [ORASURE TECHNOLOGIES INC](https://aibio.space/companies/orasure-technologies/) NASDAQ: OSUR - [SERA PROGNOSTICS, INC.](https://aibio.space/companies/sera-prognostics/) NASDAQ: SERA - [ESCALON MEDICAL CORP](https://aibio.space/companies/escalon-medical/) OTC: ESMC - [ENvue Medical](https://aibio.space/companies/envue-medical/) OTC: FEED ### Also on NYSE - [USANA HEALTH SCIENCES INC](https://aibio.space/companies/usana-health-sciences/) USNA - [Abbott Laboratories](https://aibio.space/companies/abbott-laboratories/) ABT - [LABCORP HOLDINGS INC.](https://aibio.space/companies/labcorp/) LH - [WEST PHARMACEUTICAL SERVICES INC](https://aibio.space/companies/west-pharmaceutical-services/) WST - [Pfizer](https://aibio.space/companies/pfizer-pfe/) PFE - [Xtant Medical Holdings](https://aibio.space/companies/xtant-medical/) XTNT ## Avantor annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$6.55 billion](https://www.sec.gov/Archives/edgar/data/1722482/000162828026007118/) | [$6.78 billion](https://www.sec.gov/Archives/edgar/data/1722482/000162828026007118/) | | Net income (loss) | [-$530.2 million](https://www.sec.gov/Archives/edgar/data/1722482/000162828026007118/) | [$711.5 million](https://www.sec.gov/Archives/edgar/data/1722482/000162828026007118/) | | Cash from operations | [$623.8 million](https://www.sec.gov/Archives/edgar/data/1722482/000162828026007118/) | [$840.8 million](https://www.sec.gov/Archives/edgar/data/1722482/000162828026007118/) | | Cash and equivalents | [$365.4 million](https://www.sec.gov/Archives/edgar/data/1722482/000162828026067751/) | [$261.9 million](https://www.sec.gov/Archives/edgar/data/1722482/000162828026007118/) | Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $464.3 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Avantor What is the ticker symbol of Avantor? Avantor, Inc. trades under the ticker AVTR on NYSE. Where is Avantor listed? Avantor, Inc. is listed on NYSE. Which country or territory is Avantor listed under? Our directory records Avantor, Inc. under United States. Does aibio.space cover Avantor? aibio.space lists Avantor, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What was Avantor's revenue last year? $6.55 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Avantor profitable? Avantor, Inc. reported a net loss of $530.2 million for the fiscal year ended Dec 31, 2025, and generated $623.8 million of cash from operations, per its annual report to the SEC. How much cash does Avantor have? $464.3 million in cash at Sep 30, 2026, per its 10-Q. ## Investor discussion: Avantor Members talk about Avantor (AVTR). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Avantor, newest first. Each line links the filing it comes from. 1. 2026-04-29 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1722482/000162828026028141/avtr-20260331.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:AVTR on TradingView](https://www.tradingview.com/symbols/NYSE-AVTR/). ## Listing details Avantor, Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker AVTR, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Avantor, Inc. - **Ticker**: AVTR - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/avantor/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Avantor (AVTR) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/avantor/